Panax Ginseng
Food supplement declared in France, declaration No 2020-5-1404
Panax Ginseng (BiotechUSA) is a food supplement declared in France. Status: retiré du marché le 1 August 2025. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- BiotechUSA
- Food business operator placing the product on the market
- BioTechUSA Kft.
- Status
- Retiré du marché le 1 August 2025
- Form
- Gélule
- Daily dose
- 1 gélule
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an), Sous antidiabétiques
- Objectives stated by the manufacturer (these are not authorised claims)
- Mémoire
Declaration 169036, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retiré du marché le 1 August 2025, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Panax ginseng C.A.Mey. | Parties aériennes | Autre extrait sec | 75 mg |
Additives
E904, E172, E527, E525, E470b, E551, E460
Other ingredients
Gélatine de poisson
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.
Brand : BiotechUSA